| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.1 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |